Cargando…
Current Therapies for Neonatal Hypoxic–Ischaemic and Infection-Sensitised Hypoxic–Ischaemic Brain Damage
Neonatal hypoxic–ischaemic brain damage is a leading cause of child mortality and morbidity, including cerebral palsy, epilepsy, and cognitive disabilities. The majority of neonatal hypoxic–ischaemic cases arise as a result of impaired cerebral perfusion to the foetus attributed to uterine, placenta...
Autores principales: | Tetorou, Konstantina, Sisa, Claudia, Iqbal, Arzo, Dhillon, Kim, Hristova, Mariya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421799/ https://www.ncbi.nlm.nih.gov/pubmed/34504417 http://dx.doi.org/10.3389/fnsyn.2021.709301 |
Ejemplares similares
-
Plasticity in the Neonatal Brain following Hypoxic-Ischaemic Injury
por: Rocha-Ferreira, Eridan, et al.
Publicado: (2016) -
Patterns of neonatal hypoxic–ischaemic brain injury
por: de Vries, Linda S., et al.
Publicado: (2010) -
TNF gene deletion prevents lipopolysaccharide-mediated sensitisation of the neonatal mouse brain to hypoxic-ischaemic insult
por: Sahota, A, et al.
Publicado: (2012) -
Inhibition of Signal Transducer and Activator of Transcription 3 (STAT3) reduces neonatal hypoxic‐ischaemic brain damage
por: Hristova, Mariya, et al.
Publicado: (2016) -
Neuroprotection by the histone deacetylase inhibitor trichostatin A in a model of lipopolysaccharide-sensitised neonatal hypoxic-ischaemic brain injury
por: Fleiss, Bobbi, et al.
Publicado: (2012)